Home|Journals|Articles by Year

Directory for Medical Articles

Review Article

SRP. 2020; 11(6): 26-30

Physicians’ and Senior Medical Students’ Knowledge of Drugs Contraindicated for Arterial Hypertension Treatment according to the Phystarh Study

Roman A. Bontsevich, Yana R. Vovk, Anna A. Gavrilova, Galina G. Prozorova, Galina A. Batisheva, Olga G. Kompaniets, Olena V. Myronenko.


Introduction: The relevance of work is dictated by the fact that arterial hypertension is often associated with other diseases and every physician and senior student should be aware of the contraindications to antihypertensive therapy (AT) in the most common nosologies – aV-block 2nd and 3rd degree, WPW-syndrome, gout, COPD and pregnancy.
Aim: To analyze physicians’ and medical undergraduates’ knowledge of main contraindications to AH treatment.
Material and Methods: During the multicenter study devoted to the assessment of physicians’ knowledge in treatment of AH (“PHYSTARH” study), 296 people from 5 Russian and Ukrainian cities were surveyed in 2017-2018: 44,9% – 6th grade students, 55,1% – physicians.
Results and Discussion. The study revealed an insufficient level of students’ and doctors’ knowledge of main contraindications to AH treatment. Less than half of the respondents correctly identified drugs contraindicated in pregnancy, gout, aV-block 2nd and 3rd degree, WPW-syndrome and COPD.
Conclusion. Despite the availability of antihypertensive treatment related clinical guidelines and sufficient number of information sources, the level of incorrect answers reaches a significant level in certain nosologies.

Key words: arterial hypertension, antihypertensive therapy, level of knowledge, doctors, pharmacoepidemiology, students

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.